AARON WILTON BROADWELL MD NPI 1851554786

NPI Details

Aaron Wilton Broadwell, MD is a rheumatology internal medicine in Shreveport, LA with 18 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Aaron Wilton Broadwell, MD NPI is 1851554786. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Graduation Year:2007

The provider's business location address is:

820 JORDAN ST
SUITE 201
SHREVEPORT, LA
ZIP 71101-518
Phone: (318) 221-0399
Fax: (318) 221-1940

The NPI 1851554786 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Complete ultrasound scan of joint (HCPCS:76881)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• X-ray of wrist, 2 views (HCPCS:73100)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• X-ray of upper spine, 4-5 views (HCPCS:72050)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• X-ray of middle spine, 3 views (HCPCS:72072)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• X-ray of knee, 4 or more views (HCPCS:73564)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• X-ray of both hips, 3-4 views (HCPCS:73522)
• X-ray of lower and sacral spine, minimum of 4 views (HCPCS:72110)
• X-ray of both hips, 2 views (HCPCS:73521)
• Aspiration and/or injection of fluid from small joint using ultrasound guidance (HCPCS:20604)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Aspiration and/or injection of fluid from medium joint using ultrasound guidance (HCPCS:20606)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:Q0220)
• X-ray of ankle, 2 views (HCPCS:73600)
• X-ray of elbow, 2 views (HCPCS:73070)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Injection into tendon or ligament (HCPCS:20550)

The enumeration date for this NPI number is 7/10/2008 and was last updated on 8/21/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: